# AZZ Inc: financial statements, quarterly AZZ · NYSE · CIK 8947 · [Industrials](/sectors/industrials.md) · fiscal year ends Feb 28 Pages: [Overview](/companies/azz.md) · [Financials](/companies/azz/financials.md) · [Filings](/companies/azz/filings.md) · [Insiders](/companies/azz/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/azz/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2024 (2023-11-30) | Q4 FY2024 (2024-02-29) | Q1 FY2025 (2024-05-31) | Q2 FY2025 (2024-08-31) | Q3 FY2025 (2024-11-30) | Q4 FY2025 (2025-02-28) | Q1 FY2026 (2025-05-31) | Q2 FY2026 (2025-08-31) | Q3 FY2026 (2025-11-30) | Q4 FY2026 (2026-02-28) | Q1 FY2027 (2026-05-31) | Q2 FY2027 (2026-08-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [382](/filings/0000008947-25-000008.md) | [1,538](/filings/0000008947-24-000044.md) | [413](/filings/0000008947-25-000140.md) | [409](/filings/0000008947-25-000193.md) | [404](/filings/0000008947-26-000010.md) | [352 d](/filings/0000008947-26-000068.md) | [422](/filings/0000008947-26-000162.md) | [417](/filings/0000008947-26-000187.md) | [426](/filings/0000008947-26-000010.md) | [385 d](/filings/0000008947-26-000068.md) | [449](/filings/0000008947-26-000162.md) | [487](/filings/0000008947-26-000187.md) | | Cost of revenue | $m | [293](/filings/0000008947-25-000008.md) | [1,174](/filings/0000008947-24-000044.md) | [311](/filings/0000008947-25-000140.md) | [305](/filings/0000008947-25-000193.md) | [306](/filings/0000008947-26-000010.md) | [273 d](/filings/0000008947-26-000068.md) | [318](/filings/0000008947-26-000162.md) | [316](/filings/0000008947-26-000187.md) | [324](/filings/0000008947-26-000010.md) | [298 d](/filings/0000008947-26-000068.md) | [336](/filings/0000008947-26-000162.md) | [365](/filings/0000008947-26-000187.md) | | Gross profit | $m | [88.1](/filings/0000008947-25-000008.md) | [363](/filings/0000008947-24-000044.md) | [103](/filings/0000008947-25-000140.md) | [104](/filings/0000008947-25-000193.md) | [97.8](/filings/0000008947-26-000010.md) | [78.7 d](/filings/0000008947-26-000068.md) | [104](/filings/0000008947-26-000162.md) | [101](/filings/0000008947-26-000187.md) | [102](/filings/0000008947-26-000010.md) | [87.6 d](/filings/0000008947-26-000068.md) | [112](/filings/0000008947-26-000162.md) | [122](/filings/0000008947-26-000187.md) | | Selling, general and administrative | $m | [35.3](/filings/0000008947-25-000008.md) | [142](/filings/0000008947-24-000044.md) | [32.9](/filings/0000008947-25-000140.md) | [35.9](/filings/0000008947-25-000193.md) | [39.2](/filings/0000008947-26-000010.md) | [38.3 d](/filings/0000008947-26-000068.md) | [34.6](/filings/0000008947-26-000162.md) | [32.8](/filings/0000008947-26-000187.md) | [32.5](/filings/0000008947-26-000010.md) | [30.5 d](/filings/0000008947-26-000068.md) | [35.1](/filings/0000008947-26-000162.md) | [38.3](/filings/0000008947-26-000187.md) | | Operating income | $m | [52.8](/filings/0000008947-25-000008.md) | [222](/filings/0000008947-24-000044.md) | [69.7](/filings/0000008947-25-000140.md) | [67.6](/filings/0000008947-25-000193.md) | [58.5](/filings/0000008947-26-000010.md) | [40.4 d](/filings/0000008947-26-000068.md) | [69.5](/filings/0000008947-26-000162.md) | [68.5](/filings/0000008947-26-000187.md) | [69.5](/filings/0000008947-26-000010.md) | [57.1 d](/filings/0000008947-26-000068.md) | [77.0](/filings/0000008947-26-000162.md) | [83.8](/filings/0000008947-26-000187.md) | | Interest expense | $m | [25.9](/filings/0000008947-25-000008.md) | [107](/filings/0000008947-24-000044.md) | [22.8](/filings/0000008947-25-000140.md) | [21.9](/filings/0000008947-25-000193.md) | [19.2](/filings/0000008947-26-000010.md) | [17.4 d](/filings/0000008947-26-000068.md) | [18.6](/filings/0000008947-26-000162.md) | [13.7](/filings/0000008947-26-000187.md) | [12.2](/filings/0000008947-26-000010.md) | [11.2 d](/filings/0000008947-26-000068.md) | [11.3](/filings/0000008947-26-000162.md) | [10.8](/filings/0000008947-26-000187.md) | | Income tax | $m | [8.8](/filings/0000008947-25-000008.md) | [28.5](/filings/0000008947-24-000044.md) | [11.4](/filings/0000008947-25-000140.md) | [12.2](/filings/0000008947-25-000193.md) | [12.1](/filings/0000008947-26-000010.md) | [6.1 d](/filings/0000008947-26-000068.md) | [54.9](/filings/0000008947-26-000162.md) | [25.0](/filings/0000008947-26-000187.md) | [14.5](/filings/0000008947-26-000010.md) | [8.7 d](/filings/0000008947-26-000068.md) | [14.0](/filings/0000008947-26-000162.md) | [21.3](/filings/0000008947-26-000187.md) | | Net income | $m | [26.9](/filings/0000008947-25-000008.md) | [17.9 d](/filings/0000008947-26-000068.md) | [39.6](/filings/0000008947-25-000140.md) | [35.4](/filings/0000008947-25-000193.md) | [33.6](/filings/0000008947-26-000010.md) | [20.2 d](/filings/0000008947-26-000068.md) | [171](/filings/0000008947-26-000162.md) | [89.3](/filings/0000008947-26-000187.md) | [41.1](/filings/0000008947-26-000010.md) | [15.9 d](/filings/0000008947-26-000068.md) | [52.0](/filings/0000008947-26-000162.md) | [58.5](/filings/0000008947-26-000187.md) | | Diluted EPS | $ per share | [0.92](/filings/0000008947-25-000008.md) | not reported | [(1.38)](/filings/0000008947-25-000140.md) | [1.18](/filings/0000008947-25-000193.md) | [1.12](/filings/0000008947-26-000010.md) | not reported | [5.66](/filings/0000008947-26-000162.md) | [2.95](/filings/0000008947-26-000187.md) | [1.36](/filings/0000008947-26-000010.md) | not reported | [1.72](/filings/0000008947-26-000162.md) | [1.94](/filings/0000008947-26-000187.md) | | Basic EPS | $ per share | [0.93](/filings/0000008947-25-000008.md) | not reported | [(1.38)](/filings/0000008947-25-000140.md) | [1.19](/filings/0000008947-25-000193.md) | [1.12](/filings/0000008947-26-000010.md) | not reported | [5.71](/filings/0000008947-26-000162.md) | [2.97](/filings/0000008947-26-000187.md) | [1.37](/filings/0000008947-26-000010.md) | not reported | [1.74](/filings/0000008947-26-000162.md) | [1.95](/filings/0000008947-26-000187.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfRevenue - Gross profit: us-gaap:GrossProfit - Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpense - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q3 FY2024 (2023-11-30) | FY2024 (2024-02-29) | Q1 FY2025 (2024-05-31) | Q2 FY2025 (2024-08-31) | Q3 FY2025 (2024-11-30) | FY2025 (2025-02-28) | Q1 FY2026 (2025-05-31) | Q2 FY2026 (2025-08-31) | Q3 FY2026 (2025-11-30) | FY2026 (2026-02-28) | Q1 FY2027 (2026-05-31) | Q2 FY2027 (2026-08-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [7.5](/filings/0000008947-24-000013.md) | [4.3](/filings/0000008947-25-000046.md) | [10.5](/filings/0000008947-24-000153.md) | [2.2](/filings/0000008947-24-000222.md) | [1.5](/filings/0000008947-25-000008.md) | [1.5](/filings/0000008947-26-000068.md) | [3.0](/filings/0000008947-25-000140.md) | [0.9](/filings/0000008947-25-000193.md) | [0.6](/filings/0000008947-26-000010.md) | [0.7](/filings/0000008947-26-000187.md) | [1.1](/filings/0000008947-26-000162.md) | [2.0](/filings/0000008947-26-000187.md) | | Current assets | $m | [393](/filings/0000008947-24-000013.md) | [367](/filings/0000008947-25-000046.md) | [396](/filings/0000008947-24-000153.md) | [401](/filings/0000008947-24-000222.md) | [394](/filings/0000008947-25-000008.md) | [375](/filings/0000008947-26-000068.md) | [408](/filings/0000008947-25-000140.md) | [389](/filings/0000008947-25-000193.md) | [401](/filings/0000008947-26-000010.md) | [395](/filings/0000008947-26-000187.md) | [440](/filings/0000008947-26-000162.md) | [455](/filings/0000008947-26-000187.md) | | Total assets | $m | [2,209](/filings/0000008947-24-000013.md) | [2,196](/filings/0000008947-25-000046.md) | [2,236](/filings/0000008947-24-000153.md) | [2,240](/filings/0000008947-24-000222.md) | [2,245](/filings/0000008947-25-000008.md) | [2,227](/filings/0000008947-26-000068.md) | [2,159](/filings/0000008947-25-000140.md) | [2,226](/filings/0000008947-25-000193.md) | [2,231](/filings/0000008947-26-000010.md) | [2,213](/filings/0000008947-26-000187.md) | [2,252](/filings/0000008947-26-000162.md) | [2,338](/filings/0000008947-26-000187.md) | | Current liabilities | $m | [200](/filings/0000008947-24-000013.md) | [194](/filings/0000008947-25-000046.md) | [224](/filings/0000008947-24-000153.md) | [217](/filings/0000008947-24-000222.md) | [222](/filings/0000008947-25-000008.md) | [221](/filings/0000008947-26-000068.md) | [270](/filings/0000008947-25-000140.md) | [225](/filings/0000008947-25-000193.md) | [242](/filings/0000008947-26-000010.md) | [232](/filings/0000008947-26-000187.md) | [229](/filings/0000008947-26-000162.md) | [254](/filings/0000008947-26-000187.md) | | Total liabilities | $m | [1,288](/filings/0000008947-24-000013.md) | [1,261](/filings/0000008947-25-000046.md) | [1,269](/filings/0000008947-24-000153.md) | [1,241](/filings/0000008947-24-000222.md) | [1,215](/filings/0000008947-25-000008.md) | [1,182](/filings/0000008947-26-000068.md) | [945](/filings/0000008947-25-000140.md) | [923](/filings/0000008947-25-000193.md) | [912](/filings/0000008947-26-000010.md) | [876](/filings/0000008947-26-000187.md) | [876](/filings/0000008947-26-000162.md) | [923](/filings/0000008947-26-000187.md) | | Long-term debt | $m | [980](/filings/0000008947-24-000013.md) | [953](/filings/0000008947-25-000046.md) | [930](/filings/0000008947-24-000153.md) | [913](/filings/0000008947-24-000222.md) | [880](/filings/0000008947-25-000008.md) | [852](/filings/0000008947-26-000068.md) | [570](/filings/0000008947-25-000140.md) | [567](/filings/0000008947-25-000193.md) | [535](/filings/0000008947-26-000010.md) | [478](/filings/0000008947-26-000187.md) | [481](/filings/0000008947-26-000162.md) | [468](/filings/0000008947-26-000187.md) | | Current portion of debt | $m | [0.0](/filings/0000008947-24-000013.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Shareholders' equity | $m | [687](/filings/0000008947-25-000008.md) | [701](/filings/0000008947-26-000068.md) | [967](/filings/0000008947-25-000193.md) | [1,000](/filings/0000008947-26-000010.md) | [1,030](/filings/0000008947-26-000010.md) | [1,045](/filings/0000008947-26-000187.md) | [1,214](/filings/0000008947-26-000187.md) | [1,303](/filings/0000008947-26-000187.md) | [1,319](/filings/0000008947-26-000010.md) | [1,337](/filings/0000008947-26-000187.md) | [1,376](/filings/0000008947-26-000187.md) | [1,415](/filings/0000008947-26-000187.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebtNoncurrent - Current portion of debt: us-gaap:LongTermDebtCurrent - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q3 FY2024 (2023-11-30) | Q4 FY2024 (2024-02-29) | Q1 FY2025 (2024-05-31) | Q2 FY2025 (2024-08-31) | Q3 FY2025 (2024-11-30) | Q4 FY2025 (2025-02-28) | Q1 FY2026 (2025-05-31) | Q2 FY2026 (2025-08-31) | Q3 FY2026 (2025-11-30) | Q4 FY2026 (2026-02-28) | Q1 FY2027 (2026-05-31) | Q2 FY2027 (2026-08-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [62.6 d](/filings/0000008947-25-000008.md) | [63.5 d](/filings/0000008947-26-000068.md) | [71.9](/filings/0000008947-25-000140.md) | [47.5 d](/filings/0000008947-25-000193.md) | [66.2 d](/filings/0000008947-26-000010.md) | [64.3 d](/filings/0000008947-26-000068.md) | [315](/filings/0000008947-26-000162.md) | [58.4 d](/filings/0000008947-26-000187.md) | [79.7 d](/filings/0000008947-26-000010.md) | [72.6 d](/filings/0000008947-26-000068.md) | [37.1](/filings/0000008947-26-000162.md) | [103 d](/filings/0000008947-26-000187.md) | | Capital expenditure | $m | [24.2 d](/filings/0000008947-25-000008.md) | [28.2 d](/filings/0000008947-26-000068.md) | [27.4](/filings/0000008947-25-000140.md) | [32.1 d](/filings/0000008947-25-000193.md) | [26.4 d](/filings/0000008947-26-000010.md) | [29.9 d](/filings/0000008947-26-000068.md) | [20.9](/filings/0000008947-26-000162.md) | [19.3 d](/filings/0000008947-26-000187.md) | [18.5 d](/filings/0000008947-26-000010.md) | [22.1 d](/filings/0000008947-26-000068.md) | [18.7](/filings/0000008947-26-000162.md) | [18.5 d](/filings/0000008947-26-000187.md) | | Dividends paid | $m | [7.9 d](/filings/0000008947-25-000008.md) | [7.9 d](/filings/0000008947-26-000068.md) | [7.9](/filings/0000008947-25-000140.md) | [5.1 d](/filings/0000008947-25-000193.md) | [5.1 d](/filings/0000008947-26-000010.md) | [5.1 d](/filings/0000008947-26-000068.md) | [5.1](/filings/0000008947-26-000162.md) | [6.0 d](/filings/0000008947-26-000187.md) | [6.0 d](/filings/0000008947-26-000010.md) | [6.0 d](/filings/0000008947-26-000068.md) | [6.0](/filings/0000008947-26-000162.md) | [7.2 d](/filings/0000008947-26-000187.md) | | Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | [0.0 d](/filings/0000008947-26-000068.md) | not reported | not reported | [20.0 d](/filings/0000008947-26-000010.md) | [0.0 d](/filings/0000008947-26-000068.md) | not reported | not reported | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Dividends paid: us-gaap:PaymentsOfDividends - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q4 FY2023 (2023-02-28) | Q1 FY2024 (2023-05-31) | Q2 FY2024 (2023-08-31) | Q3 FY2024 (2023-11-30) | Q1 FY2025 (2024-05-31) | Q2 FY2025 (2024-08-31) | Q3 FY2025 (2024-11-30) | Q1 FY2026 (2025-05-31) | Q2 FY2026 (2025-08-31) | Q3 FY2026 (2025-11-30) | Q1 FY2027 (2026-05-31) | Q2 FY2027 (2026-08-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [25.0](/filings/0000008947-23-000042.md) | [29.2](/filings/0000008947-24-000153.md) | [29.2](/filings/0000008947-24-000222.md) | [29.3](/filings/0000008947-25-000008.md) | [26.8](/filings/0000008947-25-000140.md) | [30.1](/filings/0000008947-25-000193.md) | [30.1](/filings/0000008947-26-000010.md) | [30.2](/filings/0000008947-26-000162.md) | [30.2](/filings/0000008947-26-000187.md) | [30.2](/filings/0000008947-26-000010.md) | [30.2](/filings/0000008947-26-000162.md) | [30.1](/filings/0000008947-26-000187.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 29,922,779 at 2026-09-30, from the cover of the [10-Q/A filed 2026-10-15](/filings/0000008947-26-000198.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:17 ET. No prices; not investment advice.